| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/PHP.13173 |
| P698 | PubMed publication ID | 31602649 |
| P50 | author | Girgis Obaid | Q84099543 |
| Shubhankar Nath | Q88146969 | ||
| P2093 | author name string | Tayyaba Hasan | |
| P2860 | cites work | Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer | Q24609433 |
| The urgent need to recover MHC class I in cancers for effective immunotherapy | Q26770165 | ||
| Autophagic death probed by photodynamic therapy | Q26796555 | ||
| Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity | Q26797280 | ||
| Immune Checkpoint Blockade in Cancer Therapy | Q26830509 | ||
| Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad | Q27330438 | ||
| Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo | Q73722498 | ||
| Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy | Q77905343 | ||
| Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy | Q80201060 | ||
| Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy | Q81888366 | ||
| Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells | Q83153040 | ||
| Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting | Q83165400 | ||
| Apoptosis, Paraptosis and Autophagy: Death and Survival Pathways Associated with Photodynamic Therapy | Q89038017 | ||
| Photodynamic activity of Temoporfin nanoparticles induces a shift to the M1-like phenotype in M2-polarized macrophages | Q89391562 | ||
| EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer | Q91195322 | ||
| Cancer Cell-targeted and Activatable Photoimmunotherapy Spares T Cells in a 3D Coculture Model | Q92692845 | ||
| Cell death: a review of the major forms of apoptosis, necrosis and autophagy | Q92927127 | ||
| Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature | Q93210412 | ||
| A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer | Q93381844 | ||
| Activatable photosensitizers for imaging and therapy. | Q37682213 | ||
| Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody | Q37686905 | ||
| Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity | Q37707162 | ||
| Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules | Q37769864 | ||
| Inducers of immunogenic cancer cell death. | Q38079937 | ||
| Autophagy: shaping the tumor microenvironment and therapeutic response. | Q38110096 | ||
| Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity | Q38116353 | ||
| ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. | Q38184935 | ||
| Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy. | Q38202871 | ||
| Apoptosis and associated phenomena as a determinants of the efficacy of photodynamic therapy | Q38307797 | ||
| Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy | Q38349813 | ||
| T cell receptor repertoire usage in cancer as a surrogate marker for immune responses | Q38376433 | ||
| T-cell receptor profiling in cancer | Q38592595 | ||
| Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy. | Q38645338 | ||
| Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade | Q38770022 | ||
| Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis | Q38796822 | ||
| Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors. | Q38821337 | ||
| Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction | Q38947679 | ||
| ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death | Q39135022 | ||
| Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin | Q39423568 | ||
| Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy | Q39593994 | ||
| Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation. | Q39763756 | ||
| Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin. | Q40000140 | ||
| Converting Cold into Hot Tumors by Combining Immunotherapies | Q40050679 | ||
| Photodynamic therapy-generated vaccine for cancer therapy | Q40363635 | ||
| Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells. | Q40411444 | ||
| Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells | Q40514714 | ||
| The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma. | Q40573262 | ||
| On the mechanism of the tumour-localising effect in photodynamic therapy | Q40666852 | ||
| Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line | Q40798474 | ||
| Somatic hypermutation of immunoglobulin genes | Q40955728 | ||
| Dynein Separately Partners with NDE1 and Dynactin To Orchestrate T Cell Focused Secretion. | Q41012876 | ||
| Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding | Q41338955 | ||
| Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma | Q41789122 | ||
| Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity | Q42215130 | ||
| Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. | Q42376109 | ||
| The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy | Q42390986 | ||
| Death pathways associated with photodynamic therapy | Q42610890 | ||
| Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer | Q42958489 | ||
| Cell death pathways in photodynamic therapy of cancer. | Q43066327 | ||
| Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy | Q43179865 | ||
| Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages | Q43603014 | ||
| Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy | Q43706301 | ||
| Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors | Q43809391 | ||
| Generation of effective antitumor vaccines using photodynamic therapy. | Q43931243 | ||
| Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids | Q43963723 | ||
| Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors | Q44017835 | ||
| Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release | Q44035557 | ||
| Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy | Q44557016 | ||
| Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients | Q44728984 | ||
| Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. | Q45970801 | ||
| Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma | Q46586294 | ||
| Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo | Q46761620 | ||
| Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade | Q47135020 | ||
| Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells. | Q47405972 | ||
| Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo | Q47599219 | ||
| Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. | Q47614555 | ||
| Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice | Q47923320 | ||
| Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors | Q48648638 | ||
| Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8+ T Cells. | Q48678664 | ||
| Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy | Q49117004 | ||
| Cell Death Pathways Associated with Photodynamic Therapy: An Update | Q49975621 | ||
| Subcellular Targeting as a Determinant of the Efficacy of Photodynamic Therapy. | Q51020373 | ||
| Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination. | Q52316326 | ||
| Enhanced Cellular Ablation by Attenuating Hypoxia Status and Reprogramming Tumor-Associated Macrophages via NIR Light-Responsive Upconversion Nanocrystals. | Q52691812 | ||
| Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. | Q53523848 | ||
| Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics | Q56594845 | ||
| Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer | Q56932855 | ||
| Luminol Chemiluminescence Reports Photodynamic Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic Efficacy | Q57788536 | ||
| A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy. | Q64973042 | ||
| Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells | Q68032753 | ||
| Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo | Q71170273 | ||
| Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells | Q71709505 | ||
| Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours | Q73192745 | ||
| Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors | Q73470587 | ||
| Boosting Tumor-Specific Immunity Using PDT | Q28067203 | ||
| Immune checkpoint blockade: a common denominator approach to cancer therapy | Q28083981 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells | Q28246367 | ||
| The future of immune checkpoint therapy | Q28259862 | ||
| Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response | Q28744245 | ||
| The role of Atg proteins in autophagosome formation | Q29547418 | ||
| Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte | Q29615441 | ||
| Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer | Q29615679 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
| Genetic basis for clinical response to CTLA-4 blockade in melanoma | Q29620594 | ||
| Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells | Q30832102 | ||
| Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. | Q31000492 | ||
| Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy | Q31983152 | ||
| Bid is required in NPe6-PDT-induced apoptosis | Q33313186 | ||
| Generation of effective vaccines against liver cancer by using photodynamic therapy | Q33367964 | ||
| Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy | Q33584715 | ||
| Involvement of the DNA mismatch repair system in antineoplastic drug resistance | Q33611788 | ||
| Pathways of antigen processing | Q33631854 | ||
| Assessing autophagy in the context of photodynamic therapy | Q33820104 | ||
| Enhanced efficacy of photodynamic therapy via a sequential targeting protocol | Q33848083 | ||
| Imaging and photodynamic therapy: mechanisms, monitoring, and optimization | Q33960755 | ||
| Efficient cross-presentation depends on autophagy in tumor cells | Q34001972 | ||
| Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils | Q34056413 | ||
| Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70. | Q34068164 | ||
| Photodynamic therapy and anti-tumour immunity. | Q34105703 | ||
| The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules | Q34128134 | ||
| DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown | Q34160434 | ||
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer | Q34210036 | ||
| Immunogenic cell death and DAMPs in cancer therapy | Q34311701 | ||
| Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms. | Q34340835 | ||
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. | Q34557699 | ||
| Generation of an effective anti-lung cancer vaccine by DTPP-mediated photodynamic therapy and mechanistic studies | Q34605795 | ||
| Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer | Q34676773 | ||
| Stimulation of anti-tumor immunity by photodynamic therapy | Q34697795 | ||
| Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation | Q35000446 | ||
| Photodynamic therapy of cancer: an update | Q35532394 | ||
| Apoptotic and autophagic responses to photodynamic therapy in 1c1c7 murine hepatoma cells | Q35534101 | ||
| Photodynamic therapy for the treatment of non-small cell lung cancer | Q35667899 | ||
| Promotion of Proapoptotic Signals by Lysosomal Photodamage | Q35811913 | ||
| Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. | Q35818203 | ||
| Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach | Q35926877 | ||
| Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients | Q36020800 | ||
| Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. | Q36057482 | ||
| Macrophages in tumor microenvironments and the progression of tumors | Q36065902 | ||
| Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy | Q36080465 | ||
| ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage | Q36235466 | ||
| Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer | Q36329765 | ||
| CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells | Q36609624 | ||
| Role of cytokines in photodynamic therapy-induced local and systemic inflammation | Q36648974 | ||
| Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer | Q36663615 | ||
| Clinical significance of immune cell infiltration within gallbladder cancer | Q36671472 | ||
| Enhanced Anti-Tumor Efficacy through a Combination of Integrin αvβ6-Targeted Photodynamic Therapy and Immune Checkpoint Inhibition | Q36723747 | ||
| Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light | Q36725545 | ||
| Recent advances in antigen processing and presentation | Q36945533 | ||
| Promotion of Proapoptotic Signals by Lysosomal Photodamage: Mechanistic Aspects and Influence of Autophagy | Q37127476 | ||
| Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade | Q37173548 | ||
| Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy | Q37191649 | ||
| IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation | Q37228002 | ||
| Combination of photodynamic therapy with anti-cancer agents | Q37232909 | ||
| Autophagy and its role in MHC-mediated antigen presentation | Q37315630 | ||
| Alarmins link neutrophils and dendritic cells | Q37399755 | ||
| Controlling natural killer cell responses: integration of signals for activation and inhibition | Q37404156 | ||
| The effect of photodynamic therapy on tumor angiogenesis | Q37427462 | ||
| Enhancement of anti-tumor immunity by photodynamic therapy | Q37599675 | ||
| A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients | Q37612098 | ||
| Landscape of tumor-infiltrating T cell repertoire of human cancers | Q37632809 | ||
| Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. | Q37676077 | ||
| P433 | issue | 6 | |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 1288-1305 | |
| P577 | publication date | 2019-11-10 | |
| P1433 | published in | Photochemistry and Photobiology | Q3381560 |
| P1476 | title | The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T-Cell Repertoire | |
| P478 | volume | 95 |
| Q90362022 | Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity | cites work | P2860 |
Search more.